51 related articles for article (PubMed ID: 27389085)
1. Antitumor Necrosis Factor Therapy Is Effective for Autoimmune Pancreatitis Type 2.
Lorenzo D; Vullierme MP; Rebours V
Am J Gastroenterol; 2020 Jul; 115(7):1133-1134. PubMed ID: 32618666
[No Abstract] [Full Text] [Related]
2. EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will Combination Pave the Way?
Torres J; Hanauer SB
Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1377-1378. PubMed ID: 38042231
[No Abstract] [Full Text] [Related]
3. RNA therapy is shining for genetic diseases.
Zheng ZM
Mol Ther Nucleic Acids; 2023 Dec; 34():102042. PubMed ID: 37876533
[No Abstract] [Full Text] [Related]
4. Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab.
Osterman MT; Sandborn WJ; Colombel JF; Peyrin-Biroulet L; Robinson AM; Zhou Q; Lewis JD
Am J Gastroenterol; 2016 Dec; 111(12):1806-1815. PubMed ID: 27670599
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review.
Martelli L; Olivera P; Roblin X; Attar A; Peyrin-Biroulet L
J Gastroenterol; 2017 Jan; 52(1):19-25. PubMed ID: 27665099
[TBL] [Abstract][Full Text] [Related]
6. Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis.
Papamichael K; Baert F; Tops S; Assche GV; Rutgeerts P; Vermeire S; Gils A; Ferrante M
J Crohns Colitis; 2017 Jan; 11(1):53-59. PubMed ID: 27402915
[TBL] [Abstract][Full Text] [Related]
7. Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.
Leone GM; Mangano K; Petralia MC; Nicoletti F; Fagone P
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836166
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring.
Lim SZ; Chua EW
Front Pharmacol; 2018; 9():1107. PubMed ID: 30349479
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance enterography evaluation of Crohn disease activity and mucosal healing in young patients.
Mojtahed A; Gee MS
Pediatr Radiol; 2018 Aug; 48(9):1273-1279. PubMed ID: 30078049
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.
Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416
[No Abstract] [Full Text] [Related]
11. Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.
Matsumoto T; Motoya S; Watanabe K; Hisamatsu T; Nakase H; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T;
J Crohns Colitis; 2016 Nov; 10(11):1259-1266. PubMed ID: 27566367
[TBL] [Abstract][Full Text] [Related]
12. Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study].
Hisamatsu T; Matsumoto T; Watanabe K; Nakase H; Motoya S; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T;
J Crohns Colitis; 2019 Sep; 13(9):1097-1104. PubMed ID: 30753377
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation.
Viazis N; Koukouratos T; Anastasiou J; Giakoumis M; Triantos C; Tsolias C; Theocharis G; Karamanolis DG
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):436-41. PubMed ID: 25874518
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease.
Tighe D; McNamara D
World J Gastroenterol; 2017 Jan; 23(3):414-425. PubMed ID: 28210077
[TBL] [Abstract][Full Text] [Related]
15. [Crohn's disease--standards of treatment 2004].
Kruis W
Praxis (Bern 1994); 2005 Oct; 94(41):1595-8. PubMed ID: 16245637
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?
Fiorino G; Danese S
J Crohns Colitis; 2016 Nov; 10(11):1257-1258. PubMed ID: 27389085
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
